These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 28070704

  • 1. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S.
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [Abstract] [Full Text] [Related]

  • 2. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis.
    Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, Chawla Y.
    Metab Brain Dis; 2013 Jun; 28(2):249-59. PubMed ID: 23494591
    [Abstract] [Full Text] [Related]

  • 3. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV, Sharma BC, Sharma P, Sarin SK.
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [Abstract] [Full Text] [Related]

  • 7. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC.
    Saudi J Gastroenterol; 2012 Feb; 18(3):168-72. PubMed ID: 22626795
    [Abstract] [Full Text] [Related]

  • 8. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS, Goyal O, Parker RA, Kishore H, Sood A.
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S.
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA.
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [Abstract] [Full Text] [Related]

  • 12. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba J, Romero-Gómez M.
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [Abstract] [Full Text] [Related]

  • 19. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P, Sharma BC, Agrawal A, Sarin SK.
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.